S21 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - S2Medical AB (publ)

Watchlist Manager

Watchlist

Price: 0.0002 EUR Market Closed

Market Cap: €53.5k

	S2Medical AB (publ) F:S21	SE
M	Mimasu Semiconductor Industry Co Ltd XMUN:MU2	JP

Profitability Summary

S2Medical AB (publ)'s profitability score is 25/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

98%

Strong 3Y Average Gross Margin

88%

Gross Margin is Increasing

77% > 98%

Negative Operating Margin

-19%

Negative 3Y Average Operating Margin

-90%

Operating Margin is Increasing

-440% > -19%

Negative Net Margin

-70%

Negative 3Y Average Net Margin

-144%

Net Margin is Increasing

-519% > -70%

Negative Free Cash Flow Margin

-9%

Negative 3Y Average Free Cash Flow Margin

-88%

Free Cash Flow Margin is Increasing

-865% > -9%

Negative ROE

-71%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-32%

ROIC is Increasing

-76% > -14%

View All

Hide

Collapse

25 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.